approval
saveRINVOQ LQ (UPADACITINIB) — FDA approval
community read0 votes
Sponsor: ABBVIE. Form: SOLUTION. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 2
same company · ±60 days · 6
- approvalupadacitinib tartrate ER: RINVOQ (UPADACITINIB) — FDA approvalMar 26, 2025
- approvalatogepant: QULIPTA (ATOGEPANT) — FDA approvalMar 21, 2025
- approvalupadacitinib tartrate ER: RINVOQ (UPADACITINIB) — FDA approvalApr 28, 2025
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalMay 1, 2025
- approvaldivalproex sodium DR: DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approvalMay 1, 2025
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalMay 1, 2025
comments(0)
5-min edit window · permanent after that